LINDSAY ORMSBY: Open Payments
NPI 1326251893 · OTTAWA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$127 in 7 payments from 6 companies in 2025. Trend: 2023 $99 · 2024 $230 · 2025 $127
Food & beverage: $127
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Alkermes, Inc. | 1 | $19 |
| Corium, LLC | 1 | $17 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: VRAYLAR, REXULTI, ARISTADA, Azstarys, INGREZZA, INVEGA SUSTENNA.
Industry payments across OH — which companies pay providers there.
